Form 4: Marimed Executive Reports Stock Transaction
Insider Transaction (Form 4)
Ryan Crandall, Chief Commercial Officer of Marimed Inc., reported multiple transactions in common stock on October 15, 2026.
Summary
- Option exercise/conversion: acquired 32,812 Common stock on October 15, 2026; holds 1,161,009 after (Direct).
- Tax/exercise-price withholding: disposed of 9,631 Common stock at $0.06 ($578) on October 15, 2026; holds 1,151,378 after (Direct).
- Option exercise/conversion: disposed of 32,812 Restricted Stock Units (RSU) on October 15, 2026; holds 65,625 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ryan Crandall — Officer (Chief Commercial Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Option exercise/conversion | Common stock | 32,812 | — | — | 1,161,009 |
| 2026-10-15 | Tax/exercise-price withholding | Common stock | 9,631 | $0 | $578 | 1,151,378 |
| 2026-10-15 | Option exercise/conversion | Restricted Stock Units (RSU) | 32,812 | — | — | 65,625 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Option exercise/conversion (32,812 shares) |
| 2026-10-15 | Tax/exercise-price withholding (9,631 shares) |
| 2026-10-15 | Option exercise/conversion (32,812 shares) |
Keywords
insider transaction, Form 4, MRMD, MARIMED INC., neutral, Ryan Crandall
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.